Skip to main content

Table 5 Adjusted p-values (Bonferroni’s multiple comparisons test) for cisplatin applications comparison of different cell types, level of significance for CAP + Cis cc, p ≤ 0.0221 and for CAP + Cis cs, p ≤ 0.041

From: Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells—an in-vitro study

Adjusted p- value for CAP + Cis cc application Adjusted p- value for CAP + Cis cs application
Cell lines 30 s 60 s 90 s 120 s 180 s 30 s 60 s 90 s 120 s 180 s
Cal 27 vs. FaDu 0.0119  > 0.9999  < 0.0001  < 0.0001  < 0.0001 0.5175  > 0.9999 0.0032  < 0.0001 0.0003
Cal 27 vs. OSC 19 0.0012 0.0001 0.0011 0.801  < 0.0001  > 0.9999  > 0.9999  > 0.9999  < 0.0001  < 0.0001
FaDu vs. OSC 19  < 0,.001  < 0.0001  < 0.0001  < 0.0001  > 0.9999  > 0.9999  > 0.9999 0.0413 0.0041 0.453